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Dyspnoea, often known as shortness of breath or 
breathlessness, is a common and often distressing symp­
tom reported by patients, and accounts for nearly half of 
hospital admissions in tertiary centres.[1] As dyspnoea 
is a symptom and not a sign, the patient experiences 
it subjectively. Dyspnoea varies greatly among individuals exposed 
to the same stimuli or with similar pathologies. This differential 
experience of the condition emanates from interactions among 
multiple physiological, psychological, social and environmental 
factors that induce secondary physiological and behavioural 
responses.[2] 
Dyspnoea not only manifests with respiratory difficulty that 
embarrasses and limits the patient, but often presents a diagnostic 
challenge for the busy clinician. In the evaluation and management 
of a patient with breathlessness, a comprehensive understanding 
of the pathophysiology of dyspnoea is essential. A structured 
clinical approach based on a thorough medical history and clinical 
examination is key to making the correct diagnosis. Special 
investigations play secondary and supplementary roles in the 
diagnosis; they are guided by the history and examination and 
may be useful in confirming the clinical suspicion of the physician. 
Disappointingly for both doctors and patients, even when the 
cause of dyspnoea has been determined, the symptoms may persist 
despite optimal therapy.
Definition
Dyspnoea is defined as ‘a subjective experience of breathing 
discomfort that consists of qualitatively distinct sensations that 
vary in intensity’, and may either be acute or chronic.[1] The 
distinct sensations often reported by patients include effort/work of 
breathing, chest tightness, and air hunger (a feeling of not enough 
air on inspiration). Dyspnoea should be assessed by the intensity 
of these sensations, the degree of distress involved, and its burden 
or impact on instrumental activities of daily living. Dyspnoea is a 
normal symptom of heavy exertion but may be pathological if it 
occurs in unexpected situations. It derives from interactions among 
multiple physiological, psychological, social, and environmental 
factors, and may induce secondary physiological and behavioural 
responses. Its management typically depends on the underlying 
cause.
Pathophysiology
Dyspnoea is a complex symptom that arises from physiological 
impairment and alerts one to the possibility of threatened homeo­
stasis. The discomfort primarily occurs as a result of either 
cardiovascular or respiratory system compromise, but may also be 
attributed to metabolic derangements, neuromuscular disorders 
or psychogenic conditions. The condition is perceived as increased 
respiratory work/effort, tightness, or air hunger, which are caused 
by pulmonary ventilation not matching the drive to breathe.[1,3] 
The dissociation between pulmonary ventilation and respiratory 
drive arises from a mismatch between afferent receptors in the 
airways, lungs and chest wall structures, and central respiratory 
motor activity. Physiological pathways lead to shortness of breath 
via specific acid­sensing ion channels, mechanoreceptors and 
lung receptors located in different zones of the respiratory 
apparatus. Chemoreceptors in the carotid bodies and medulla 
supply information with regard to the blood gas levels of O2, 
CO2 and H+. In the lungs, juxtacapillary receptors are sensitive 
to pulmonary interstitial oedema, while stretch receptors signal 
bronchoconstriction. Muscle spindles in the chest wall signal the 
stretch and tension of the respiratory muscles. Efferent signals are 
the motor neuronal signals descending to the respiratory muscles, 
the most important being the diaphragm. 
Three main components contribute to dyspnoea: afferent signals, 
efferent signals, and central information processing. The central 
processing in the brain compares the afferent and efferent signals 
and dyspnoea results when a mismatch occurs between the two, 
such as when the need for ventilation (afferent signalling) is 
not being met by physical breathing (efferent signalling). The 
afferent receptors allow the brain to assess whether the efferent or 
motor commands to the ventilatory muscles are effective, meeting 
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the required demands of airway pressure, air flow, and/or lung 
movement. When these respond inappropriately to the command, 
the intensity of the dyspnoea increases.[4] The sensory cortex is 
simultaneously activated when motor signals are sent to the chest 
wall, resulting in the conscious sensation of muscular effort and 
breathlessness.[5] There is also a strong psychological component 
to dyspnoea, as some people may become aware of their breathing 
in such circumstances but not experience the distress typical of the 
condition.
Causes of dyspnoea
Dyspnoea is primarily of respiratory or cardiac origin, with almost 
90% of all cases being due to asthma, heart failure, myocardial 
ischaemia, chronic obstructive pulmonary disease (COPD), pneu­
monia, and psychogenic disorders.[6] In the South African (SA) 
context, where there is a high burden of HIV infection, a broader 
differential needs to be incorporated that includes infectious diseases 
such as tuberculosis, Pneumocystis pneumonia, aspergillosis and 
acute infective exacerbations of bronchiectasis. Furthermore, due 
to the high prevalence of interpersonal violence in SA, a significant 
proportion of patients presenting to emergency centres have dyspnoea 
related to trauma, with the cause dependent on the mechanism 
of injury and organ system involved. Table 1 highlights important 
causes of dyspnoea. 
Clinical evaluation
A patient presenting with dyspnoea often complains of difficulty 
breathing or chest discomfort and may present to a general practitioner, 
community health centre or emergency centre. A problematic aspect 
of the clinician­patient interface is the complicated use of language in 
articulating the patient’s experience, which may be a manifestation of 
biological, social and psychological challenges facing an individual. 
A biopsychosocial classification of dyspnoea follows the acronym 
DYSPNEA:
D: Depression
Y: Yearning for peace, forgiveness, etc.
S: Social issues
P: Physical problems, pain
N: Non­acceptance or spiritual/existential distress
E: Economic or financial distress
A: Anxiety or anger.
There is always a certain degree of concern with regard to 
understanding the different types of dyspnoea that stem from 
different neurophysiological pathways (sequentially or in parallel) 
and viewing them as socioculturally diverse ways of describing the 
same neurophysiological phenomenon.
In the initial assessment/triage it is essential to establish the 
degree of urgency by determining the duration of the dyspnoea, 
the severity of the symptoms and whether the condition is acute 
or chronic. It is imperative to detect warning signs that require 
immediate attention, as the patient may have a life­threatening 
cause of dyspnoea. These ‘red flags’ include hypotension, a high 
respiratory rate, an altered mental status, hypoxia, cyanosis, stridor, 
breathing effort without air movement, chest wall retractions, 
tracheal deviation and unilateral breath sounds (underlying 
pneumothorax), and an unstable arrhythmia (Table 2).[7] The 
presence of any of these mandates emergency assessment of the 
patient, including supplementation of oxygen and consideration of 
endotracheal intubation.
With regard to the clinical evaluation, there are two major 
categories of patients: those with new onset of breathing 
discomfort for whom the underlying cause of dyspnoea has not 
yet been determined; and those with known cardiovascular, 
Table 1. Causes of dyspnoea
System Pathology
Cardiac Arrhythmia
Atrial fibrillation
Sinus tachycardia
Sick sinus syndrome/bradycardia
Ventricular tachycardia/fibrillation
Myocardial
Cardiomyopathy
Hypertensive heart disease
Congestive cardiac failure
Myocarditis
Coronary vessels
Myocardial ischaemia
Acute myocardial infarction
Chronic ischaemic myocardial dysfunction
Valvular
Aortic stenosis/regurgitation
Mitral stenosis/regurgitation
Tricuspid regurgitation/stenosis
Pulmonic regurgitation/stenosis
Pericardial
Pericarditis
Pericardial effusion
Pericardial tamponade
Pericardial constriction
Congenital
Atrial septal defect
Tetralogy of Fallot
Respiratory Obstructive
Asthma
Chronic obstructive pulmonary disease
Bronchitis
Bronchiectasis
Bronchiolitis obliterans
Intrabronchial neoplasm
Tracheomalacia
Obstructive sleep apnoea
Restrictive
Interstitial lung disease
Sarcoidosis
Kyphoscoliosis
Obesity
Pleural disease/effusion
Pneumothorax
Alveolar
Bronchoalveolar carcinoma
Tuberculosis
Bacterial pneumonia
Pneumocystis pneumonia
Eosinophilic pneumonitis
Aspiration
Hypersensitivity pneumonitis
Interstitial
Drugs (methotrexate, amiodarone)
Radiation therapy
Passive congestion/pulmonary oedema
Lymphangitic spread of malignancy
Vascular
Pulmonary embolus (acute/chronic)
Idiopathic pulmonary hypertension
Continued …
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respiratory, or neuromuscular disease who are experiencing 
worsening symptoms. For the former, evaluation is focused 
on discovering an underlying abnormality or diagnosis; for 
the latter, the goal is to discern whether there is deterioration 
of a known disorder or emergence of a new problem. In a 
patient with new onset of dyspnoea, the history and physical 
examination remain the mainstay of diagnostic evaluation. 
Among those for whom diagnosis remains elusive, specialist 
referral should be considered (e.g. to a pulmonologist, cardio­
logist, or multidisciplinary dyspnoea clinic), which will proba­
bly lead to identification and successful management of the 
underlying cause. Psychogenic dyspnoea may be a significant 
challenge for primary care physicians. The typical scenario is 
a young person without a notable medical history, with normal 
oxygen saturation in room air, who complains of breathlessness 
and tingling around the mouth, fingers and toes. Psychogenic 
dyspnoea responds well to reassurance (and acknowledgement 
of the underlying problem).
Medical history
A complete history should emphasise any coexisting cardiac and 
pulmonary comorbidities and symptoms, as the cardiac and pulmonary 
systems comprise the most common causes of dyspnoea. Moreover, the 
history should determine the character, onset, duration, associations, 
severity, relation to exertion and any exacerbating/relieving factors. 
The presence of cough may imply asthma or chest infection, and 
cough combined with a change in the appearance of the sputum 
may be related to an exacerbation of COPD. Chest pain during 
dyspnoea may be caused by cardiac conditions or pleural disease (the 
description of the quality of the chest pain is useful). Pleuritic chest 
pain results from pericarditis, pneumonia, pulmonary embolism, 
pneumothorax, or pleuritis. Chest pain almost always occurs in 
spontaneous pneumothorax, while dyspnoea is the second most 
common symptom. Anginal chest pain accompanied by shortness 
of breath may signify ischaemia associated with left ventricular 
dysfunction. Sudden shortness of breath at rest suggests pulmonary 
embolism or pneumothorax. Spontaneous pneumothorax should be 
considered in patients with COPD, cystic fibrosis, or AIDS. A history 
of scuba diving may suggest barotrauma. Vehicle airbag trauma 
has been reported to cause pneumothorax. The clinician should 
note a history of penetrating or non­penetrating trauma. Severe 
respiratory distress continuing over 1 ­ 2 hours suggests congestive 
cardiac failure (CCF) or asthma. The presence of comorbidities such 
as hypertension, hyperlipidaemia, diabetes mellitus, and obstructive 
sleep apnoea increase the likelihood of developing CCF. 
Elements of the social history include smoking, alcohol use and 
illicit drug use. A family history of coronary artery disease, dilated 
cardiomyopathy, and sudden cardiac death may provide important 
information regarding the possible aetiology of CCF. Dyspnoea 
may also present as orthopnoea (breathlessness on assuming the 
supine position) and paroxysmal nocturnal dyspnoea (attacks of 
breathlessness that occur at night and may awaken the sleeping 
patient). Patients with CCF tend to increase the number of pillows 
on which they sleep to avoid symptoms of orthopnoea: the number 
of pillows is a marker of the severity of heart failure. Advanced or 
end­stage heart failure can present with an abnormal pattern of 
breathing characterised by periods of hyperapnoea and Cheyne­
Stokes respiration, which is a marker of poor prognosis.
Non­respiratory causes of dyspnoea should be considered, 
including anaemia, acidosis and drug poisoning. The attending 
physician should enquire about indigestion or dysphagia, which may 
indicate gastro­oesophageal reflux or aspiration. Anxiety symptoms 
may imply psychogenic causes of dyspnoea, but organic causes 
should always be excluded first: a diagnosis of hyperventilation 
syndrome cannot be made before organic disease is ruled out. 
Medication use is another important consideration, especially 
drugs with potential adverse cardiopulmonary effects (e.g. beta­
blockers, eyedrops). Drugs may cause haemolytic anaemia (quinidine 
Table 1. (continued) Causes of dyspnoea
System Pathology
Haematological Anaemia
Methaemoglobinaemia
Sulfhaemoglobinaemia
Carbon monoxide poisoning
Thrombotic thrombocytopenic purpura
Abdominal Ascites
Gastro­oesophageal reflux disease
Peptic ulcer disease
Metabolic Thyroid disease
Cushing’s syndrome
Psychogenic Anxiety and panic attacks
Neurological Amyotropic lateral sclerosis
Polio
Other acute viral anterior horn infections
Guillain­Barré syndrome
Myasthenia gravis
Paraneoplastic myasthenia syndrome
Physiological Exercise
Normal ageing
Deconditioning
Obesity
Uncommon 
causes
Pulmonary contusion
Angio­oedema
Trauma
Foreign body aspiration
Retrosternal goitre
Vocal cord dysfunction
Pulmonary hypertension
Hepatopulmonary syndrome
Pulmonary arteriovenous malformations
Mesothelioma
Pleuritis
Haemothorax
Cardiac drugs
Superior vena cava syndrome
Pulmonary leukostasis
Tetanus
Botulism
Anaphylaxis
Table 2. ‘Red flags’ for serious forms of dyspnoea
Hypotension
Respiratory rate >40 breaths/minute
Altered mental status
Hypoxia
Cyanosis
Stridor
Breathing effort without air movement
Tracheal deviation with unilateral breath sounds
Unstable arrhythmia
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and penicillin); methaemoglobinaemia (nitrites and nitrates); sulf­
haemoglobinaemia (dapsone and sulfonamides); and acute or chronic 
fibrosis (nitrofurantoin or amiodarone). Aspirin sensitivity is a cause 
of asthma in a significant number of patients.
Clinical examination
General appearance and vital signs. To determine the severity 
of dyspnoea, one should carefully observe respiratory effort, use 
of accessory muscles, mental status, and ability to speak. Pulsus 
paradoxus may exist in COPD, asthma, cardiac tamponade or 
pericardial constriction. Stridor indicates upper airway obstruction. 
It may be necessary to obtain a rectal temperature to detect fever, as 
oral airflow may decrease the oral temperature. 
Extremities. The lower extremities should be inspected for 
oedema and any signs suggestive of deep venous thrombosis, and the 
digits examined for clubbing or cyanosis.
Neck. Distention of the neck veins may imply cor pulmonale caused 
by severe COPD, CCF, or cardiac tamponade. The thyroid size should 
be assessed, as CCF may result from hyper­ or hypothyroidism. The 
trachea should be central and the presence of stridor excluded.
Cardiac and pulmonary disease. Palpate the chest for sub­
cutaneous emphysema and crepitus, and percuss for dullness, 
an indication of consolidation or effusion. Hyper­resonance on 
percussion suggests pneumothorax or bullous emphysema. The 
clinician should always auscultate the heart and lungs for murmurs or 
extra heart sounds; absent breathing sounds may be consistent with 
pneumothorax or pleural effusion. Wheezing is usually consistent 
with obstructive lung disease, but can be caused by pulmonary 
oedema or pulmonary embolism. Rales are present in pulmonary 
oedema, pneumonia or restrictive lung pathology. A rapid or 
irregular pulse may signify a dysrhythmia. An S3 gallop suggests 
left ventricular systolic dysfunction in CCF, while an S4 gallop may 
indicate left ventricular dysfunction in hypertension or ischaemia. A 
loud P2 may be heard in patients with pulmonary hypertension or cor 
pulmonale. Murmurs can be an indirect sign of CCF or valvular heart 
disease, and distant heart sounds can point to cardiac tamponade.
Abdomen. The clinician should look for hepatomegaly and ascites. 
Assessing for hepatojugular reflux is a valid bedside maneouvre in the 
diagnosis of CCF in patients with acute dyspnoea.
Relevant special investigations
Chest radiography (CXR). This has a great potential in aiding the 
diagnosis of many lung disorders that cause acute dyspnoea and 
chest pain. The physician should be aware that the sensitivity of CXR 
is rather low in the diagnosis of pneumothorax, pleural effusion 
and pulmonary oedema, particularly in bedside­acquired images. 
Nevertheless, thoracic imaging by means of CXR plays a crucial role 
in the diagnostic process, because it allows a panoramic view, at the 
same time being cost­effective, safe and time saving.
Electrocardiography (ECG). In African patients presenting with 
heart failure common causes include hypertension (43.2%), idio­
pathic dilated cardiomyopathy (21.0%), rheumatic heart disease 
(17.2%), and ischaemic heart disease (7.7%).[8] The ECG is unlikely 
to be normal in the presence of structural heart disease. However, in 
black patients, ECG abnormalities can occur among those without 
heart disease; up to 13% of these patients may present with significant 
Q waves in the absence of myocardial ischaemia.
Cardiopulmonary exercise tests. These can be particularly helpful 
in the evaluation of patients in whom an initial evaluation is 
unrevealing or in those in whom multiple problems may contribute 
to dyspnoea. Identifying non­respiratory causes of exercise limitation 
(e.g. leg discomfort, fatigue or weakness) is important, because these 
often coexist with breathing discomfort. 
The D-dimer. This is a component of the evaluation of patients 
with suspected pulmonary embolism. As with many screening tests, 
the sensitivity of D­dimer is much greater than its specificity, and 
its positive predictive value is poor. Therefore, its primary value 
is to rapidly identify patients with a low probability of pulmonary 
embolism, particularly in outpatient settings. There is evidence that 
its negative predictive value is poor in hospitalised patients, especially 
after several days of hospitalisation, or in patients >60 years of age.
 Brain natriuretic peptide (BNP). Routine use of BNP in all 
patients presenting with acute dyspnoea is not recommended. In 
acute­care settings such as an emergency department, the sensitivity 
of BNP or N­terminal (NT)­pro­BNP is substantially higher than 
its specificity, and its use is greatest for ruling out heart failure as a 
cause of acute dyspnoea in patients with a low to intermediate pretest 
probability of heart failure. In general, heart failure is unlikely at BNP 
values <100 pg/mL and is very likely at BNP values >500 pg/mL. 
Point-of-care ultrasound scans and echocardiography. These 
may aid clinicians in the diagnosis of acute cardiogenic pulmonary 
oedema. In patients with a moderate to high pretest probability, a 
point­of­care ultrasound/echocardiogram can be used to strengthen 
an emergency physician’s working diagnosis of acute cardiogenic 
pulmonary oedema. In patients with a low pretest probability, a 
negative study can almost exclude the possibility of the condition. 
A clinical decision rule (pulmonary embolism rule-out criteria). 
To exclude pulmonary embolism among patients with a low suspicion 
a clinical decision rule has been developed.[9] Pulmonary embolism can 
also be safely excluded on the basis of a Wells score of ≤4, combined 
with a negative qualitative point­of­care D­dimer test result.[10]
Management
In a patient with dyspnoea, the initial focus should be on optimising 
treatment of the underlying disease and relieving symptoms.
Supplemental oxygen. Although supplemental oxygen reduces 
the mortality rate in chronically hypoxaemic patients with COPD, 
there are conflicting data about its ability to relieve breathlessness. 
Beneficial effects of oxygen could be related to changes in chemo­
receptor stimulation, changes in breathing pattern, and/or stimulation 
of receptors related to gas flow through the upper airway. Oxygen 
therapy may be useful for patients with advanced heart or lung 
disease, in particular those who are hypoxaemic at rest. Long­term 
oxygen therapy (LTOT) may be of great help in patients with COPD. 
Patients with stable COPD and a resting PaO2 ≤7.3 kPa should be 
assessed for LTOT. The latter should not be routinely administered to 
patients who are breathless when there is no evidence of benefit, as it 
is expensive and may sometimes be associated with increased harm.
Pharmacological therapy. Opioids have been the most widely 
studied agents in the treatment of dyspnoea. Short­term admin­
istration reduces breathlessness in patients with a variety of condi­
tions, including advanced COPD, interstitial lung disease, cancer, 
and CCF. However, evidence of long­term efficacy is limited and 
conflicting. Recent evidence­based clinical guidelines recommend 
that opioids be considered on an individualised basis for palliation 
of unrelieved dyspnoea in patients with advanced cardiopulmonary 
disease despite otherwise adequate treatment of the underlying 
condition, with due consideration to patient history, comorbid 
conditions, and risk of respiratory depression.
Pulmonary rehabilitation. This is an integral component of the 
management of patients with chronic lung disease. Among the beneficial 
effects of pulmonary rehabilitation are a reduction in exertional dyspnoea 
during exercise and improved exercise tolerance, as well as a decrease in 
self­reported dyspnoea with activity. Exercise is the main component 
of pulmonary rehabilitation responsible for these improvements, 
but it is less clear whether mechanisms leading to improvement in 
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symptom, and its experience is subjective and varies greatly among 
individuals exposed to the same stimuli or with similar pathologies. 
This differential experience of dyspnoea among individuals emanates 
from interactions among multiple physiological, psychological, social, 
and environmental factors that induce secondary physiological and 
behavioural responses. The management of dyspnoea will depend on 
the underlying cause. 
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dyspnoea are mainly due to improvements in conditioning, pacing of 
activities, desensitisation to respiratory sensations or affective distress, 
or a combination of these effects. Evidence that other components of 
pulmonary rehabilitation (e.g. education to improve inhaler technique, 
medication adherence, pacing activities, or breathing techniques) 
ameliorate dyspnoea independent of exercise is inconsistent, but it is 
likely that individual characteristics, such as motivation, are relevant. 
In COPD, pulmonary rehabilitation may result in decreased ventilatory 
requirements and respiratory rate during ambulation, thereby decreasing 
the risk for developing dynamic hyperinflation. There is evidence 
that patients with COPD who undergo 6 weeks of exercise training 
experience comparable small decreases in dyspnoea intensity, regardless 
of whether or not they demonstrate improved exercise capacity.
Other non-pharmacological approaches. Patients with dyspnoea 
often report that movement of cool air reduces breathlessness, 
and laboratory studies have shown that cold air directed on the 
face decreases dyspnoea induced in healthy individuals. Increased 
respiratory muscle effort, associated with high ventilatory demand 
relative to respiratory muscle capacity, may contribute to dyspnoea 
in many patients with chronic respiratory disease. By reducing the 
demand on the respiratory muscles, non­invasive ventilation might 
reduce dyspnoea. However, few studies of non­invasive ventilation 
have used dyspnoea as an endpoint.
Conclusion
Dyspnoea is a common and often distressing symptom and a frequent 
reason for general practitioner and clinic visits. Dyspnoea is 
a 
